Prospera Financial Services Inc Acquires 26,631 Shares of Bath & Body Works, Inc. $BBWI

Prospera Financial Services Inc increased its holdings in Bath & Body Works, Inc. (NYSE:BBWI) by 195.2% during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The fund owned 40,277 shares of the company’s stock after acquiring an additional 26,631 shares during the period. Prospera Financial Services Inc’s holdings in Bath & Body Works were worth $1,207,000 at the end of the most recent quarter.

Other hedge funds have also added to or reduced their stakes in the company. Stonehage Fleming Financial Services Holdings Ltd purchased a new stake in shares of Bath & Body Works in the second quarter worth approximately $33,000. SVB Wealth LLC purchased a new position in shares of Bath & Body Works during the first quarter valued at approximately $35,000. Geneos Wealth Management Inc. grew its holdings in Bath & Body Works by 217.7% during the first quarter. Geneos Wealth Management Inc. now owns 1,169 shares of the company’s stock worth $35,000 after buying an additional 801 shares in the last quarter. Parallel Advisors LLC raised its position in Bath & Body Works by 63.3% in the 2nd quarter. Parallel Advisors LLC now owns 1,241 shares of the company’s stock valued at $37,000 after buying an additional 481 shares during the last quarter. Finally, GKV Capital Management Co. Inc. purchased a new stake in Bath & Body Works in the 1st quarter valued at $69,000. Institutional investors and hedge funds own 95.14% of the company’s stock.

Bath & Body Works Stock Up 1.8%

BBWI opened at $22.36 on Thursday. Bath & Body Works, Inc. has a twelve month low of $21.71 and a twelve month high of $41.87. The company’s 50-day moving average price is $25.84 and its two-hundred day moving average price is $28.66. The stock has a market cap of $4.61 billion, a price-to-earnings ratio of 6.63, a PEG ratio of 0.86 and a beta of 1.53.

Bath & Body Works (NYSE:BBWI) last issued its quarterly earnings results on Thursday, August 28th. The company reported $0.37 earnings per share (EPS) for the quarter, hitting the consensus estimate of $0.37. Bath & Body Works had a net margin of 9.88% and a negative return on equity of 48.43%. The company had revenue of $1.55 billion during the quarter, compared to analyst estimates of $1.55 billion. During the same quarter last year, the business posted $0.37 EPS. Bath & Body Works’s quarterly revenue was down .8% compared to the same quarter last year. Bath & Body Works has set its Q3 2025 guidance at 0.370-0.45 EPS. FY 2025 guidance at 3.350-3.600 EPS. As a group, sell-side analysts anticipate that Bath & Body Works, Inc. will post 3.3 earnings per share for the current year.

Bath & Body Works Dividend Announcement

The company also recently announced a quarterly dividend, which will be paid on Friday, December 5th. Shareholders of record on Friday, November 21st will be paid a $0.20 dividend. The ex-dividend date is Friday, November 21st. This represents a $0.80 annualized dividend and a dividend yield of 3.6%. Bath & Body Works’s payout ratio is presently 23.74%.

Analyst Upgrades and Downgrades

A number of research firms have issued reports on BBWI. Morgan Stanley lifted their price objective on shares of Bath & Body Works from $40.00 to $43.00 and gave the stock an “overweight” rating in a report on Wednesday, November 5th. Raymond James Financial restated a “market perform” rating on shares of Bath & Body Works in a report on Wednesday. Barclays reduced their price objective on shares of Bath & Body Works from $32.00 to $28.00 and set an “equal weight” rating for the company in a research report on Monday, October 20th. Jefferies Financial Group dropped their target price on shares of Bath & Body Works from $32.00 to $28.50 and set a “hold” rating on the stock in a research report on Monday, October 13th. Finally, Telsey Advisory Group reaffirmed an “outperform” rating and issued a $38.00 target price on shares of Bath & Body Works in a report on Thursday, August 28th. Ten analysts have rated the stock with a Buy rating and seven have issued a Hold rating to the stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and an average target price of $38.18.

Bath & Body Works Profile

Bath & Body Works, Inc is a specialty retailers and home to America’s Favorite Fragrances, offering a breadth of exclusive fragrances for the body and home, including the selling collections for fine fragrance mist, body lotion and body cream, 3-wick candles, home fragrance diffusers and liquid hand soap.